PharmacoEconomics & Outcomes News

, Volume 781, Issue 1, pp 20–20 | Cite as

Health benefits of PCSK9 inhibitors outweigh costs

Clinical study
  • 14 Downloads

Reference

  1. Cheng W-H, et al. PCSK9 Inhibitors Show Value for Patients and the US Health Care System. Value in Health : 17 Jun 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.05.014

Copyright information

© Springer International Publishing AG  2017

Personalised recommendations